Skip to main content
Premium Trial:

Request an Annual Quote

Taikong Corporation, Huai-Jen Tsai, Multi-Gene Vascular Systems

Taikong Corporation and Huai-Jen Tsai have been awarded US Patent 7,365,177, “Recombinant plasmid expressing two fluorescence genes.”
The inventor listed in the patent is Huai-Jen Tsai.
According to its abstract, the patent describes recombinant plasmids comprising (a) a ubiquitous promoter, (b) one fluorescent gene, the gene being operably liked to and inserted downstream of the ubiquitous promoter, (c) a skin-specific or muscle-specific promoter, and (d) another fluorescent gene, the gene being operably linked to and inserted downstream of the skin-specific or muscle specific promoter. The ubiquitous promoter and the skin-specific or muscle promoter have the adverse directional property and are located upstream of the fluorescent gene.

Multi-Gene Vascular Systems has been awarded US Patent 7,364,725, “Endothelial cells engineered to express or overexpress fibulin-5 and a growth factor.”
The inventor listed on the patent is Moshe Flugelman
The invention relates to endothelial and smooth muscle cells genetically altered to express or over-express one or more cell adhesion factors, its abstract said. The patent also relates to cells that have been genetically altered to express or over-express both cell proliferation growth factor(s) and cell adhesion factor(s). In addition, the present invention relates to nucleic acid constructs and nucleic acid construct systems that encode the cell adhesion and cell proliferation growth factors, and that are used to transfect/transform the cells so that they express the factors.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.